Hualan Biological Bacterin Inc.

Shenzhen Stock Exchange 301207.SZ

Hualan Biological Bacterin Inc. Market Capitalization on January 27, 2025: USD 1.41 B

Hualan Biological Bacterin Inc. Market Capitalization is USD 1.41 B on January 27, 2025, a -28.00% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Hualan Biological Bacterin Inc. 52-week high Market Capitalization is USD 2.12 B on March 15, 2024, which is 50.04% above the current Market Capitalization.
  • Hualan Biological Bacterin Inc. 52-week low Market Capitalization is USD 1.32 B on August 23, 2024, which is -6.50% below the current Market Capitalization.
  • Hualan Biological Bacterin Inc. average Market Capitalization for the last 52 weeks is USD 1.64 B.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
SV Wall Street
Shenzhen Stock Exchange: 301207.SZ

Hualan Biological Bacterin Inc.

CEO Ms. Wenjue An
IPO Date Feb. 18, 2022
Location China
Headquarters No. 1, Westlands Road
Employees 770
Sector Healthcare
Industries
Vaccines Biotechnology
Description

Hualan Biological Bacterin Inc. engages in the research, development, production, and sale of vaccines in China. It offers It offers influenza virus split vaccines, quadrivalent influenza virus split vaccines, H1N1 influenza virus split vaccines, ACYW135 meningococcal polysaccharide plague vaccines, recombinant hepatitis B vaccines, and group A and C meningococcal polysaccharide vaccines, as well as genetic engineering vaccines for human use. The company was founded in 2005 and is based in Xinxiang, China. Hualan Biological Bacterin Inc. was formerly a subsidiary of Hualan Biological Engineering Inc.

StockViz Staff

February 2, 2025

Any question? Send us an email